EE342 Evaluation of the Cost-Effectiveness of Dapagliflozin Vs. Empagliflozin for Treating Heart Failure with Reduced Ejection Fraction in the United States
Abstract
Authors
R. Nechi A. Rane R. Karaye C. Ndikumukiza S. Alsahali A. Jatau C.R. Zoni A. Alanazi I. Karaye I. Yunusa